Science & Enterprise subscription

Follow us on Twitter

  • As the U.S. enters its Independence Day in the midst of its worst-ever pandemic, a divided public most trusts its h… https://t.co/umw9fDWuvJ
    about 7 hours ago
  • New post on Science and Enterprise: Infographic – Health Agencies Trusted for Covid-19 Info https://t.co/RerieMYQgn #Science #Business
    about 7 hours ago
  • Change the name of the Washington NFL team? A respondent to @joshtpm has a brilliant idea ... Washington Dukes, for… https://t.co/J9P4LKG2PT
    about 21 hours ago
  • A medical software team designed a mobile app that records and analyzes a person's sounds and sleep positions to de… https://t.co/NB99HQUWpC
    about 1 day ago
  • New post on Science and Enterprise: Mobile App Screens for Sleep Apnea https://t.co/N8gTn2zWhe #Science #Business
    about 1 day ago

Please share Science & Enterprise

Weak Covid-19 App Privacy Found, Risk Software in Works

Phone on desk

An analysis of mobile apps tracking Covid-19 cases and symptoms finds most lack basic privacy protections, despite collecting personal identifying information. . . . → Read More: Weak Covid-19 App Privacy Found, Risk Software in Works

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Infographic – High Hopes for Covid-19 Therapy, Vaccine

Therapy, vaccine expectations

Sizeable majorities of Americans expect to see treatments and a vaccine for Covid-19 in the next 12 months, but also another outbreak of the disease. . . . → Read More: Infographic – High Hopes for Covid-19 Therapy, Vaccine

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Data Company Building Covid-19 Early Warning System

Apple smartwatch

An initiative is underway to detect early signs of Covid-19 infections from individuals’ activity and sleep data collected with smartphones and wearable devices. . . . → Read More: Data Company Building Covid-19 Early Warning System

Large-Scale Antibody Screening Device in Development

SARS-Cov-2 virus

A system to quickly screen for human antibodies that neutralize SARS-CoV-2 or other infectious viruses is being developed at Texas A&M University. . . . → Read More: Large-Scale Antibody Screening Device in Development

Covid-19 Antibody Therapy Trial Underway

SARS-Cov-2 viruses

A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles. . . . → Read More: Covid-19 Antibody Therapy Trial Underway

Infographic – Major Cities Far Short of Herd Immunity

Herd immunity chart

The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with antibodies against the coronavirus. . . . → Read More: Infographic – Major Cities Far Short of Herd Immunity

Drug Added to Covid-19 Lung Disease Trial

lung illustration

A clinical trial evaluating numerous therapies for a serious lung complication of Covid-19 infections is adding a drug to treat glaucoma to the study. . . . → Read More: Drug Added to Covid-19 Lung Disease Trial

Antibody Drug Biotech Raises $105M in Venture Funds

Human B-cell

A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds